Search research articles
Contact Us
Filters
Showing results (81-90 of 185) with videos related to
Page
of 19
Sort By:
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
December 24, 2005
High efficacy of gemcitabine and cisplatin plus trastuzumab in patients with HER2-overexpressing metastatic breast cancer: a phase II study
H J Stemmler, S Kahlert, O Brudler, et al.
British Journal of Cancer
|
February 4, 2015
Early detection of metastatic disease in asymptomatic breast cancer patients with whole-body imaging and defined tumour marker increase
D Di Gioia, P Stieber, G P Schmidt, et al.
Anticancer Research
|
November 1, 1989
Repeated blast crisis (BC) of changing morphology, immunologic phenotype and cytogenetics in chronic myeloid leukemia (CML)
U Jehn, J Mittermüller, L Greither, et al.
Anticancer Research
|
September 2, 1999
CA19-9: a pedictor of response in pancreatic cancer treated with gemcitabine and cisplatin
V Heinemann, M M Schermuly, P Stieber, et al.
Cancer Chemotherapy and Pharmacology
|
September 16, 2005
High efficacy of gemcitabine and cisplatin in patients with predominantly anthracycline- and taxane-pretreated metastatic breast cancer
V Heinemann, H J Stemmler, A Wohlrab, et al.
Anti-Cancer Drugs
|
October 14, 2005
Lasting remission following multimodal treatment in a patient with metastatic breast cancer
H J Stemmler, H Menzel, C Salat, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
July 16, 2014
Tumor markers CEA and CA 19-9 correlate with radiological imaging in metastatic colorectal cancer patients receiving first-line chemotherapy
M Michl, J Koch, R P Laubender, et al.
Annals of Hematology
|
April 22, 1999
Long-term outcome of hairy cell leukemia treated with 2-chlorodeoxyadenosine
U Jehn, R Bartl, H Dietzfelbinger, et al.
British Journal of Cancer
|
April 13, 2013
Cytokeratin 19-fragments (CYFRA 21-1) as a novel serum biomarker for response and survival in patients with advanced pancreatic cancer
S Boeck, C Wittwer, V Heinemann, et al.
Virchows Archiv : an International Journal of Pathology
|
December 10, 2020
Biomarker alterations associated with distinct patterns of metastatic spread in colorectal cancer
M Michl, F Taverna, J Kumbrink, et al.
Page
of 19
Search research articles
Search
Showing results (81-90 of 185) with videos related to
Sort By:
Page
of 19
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
December 24, 2005
High efficacy of gemcitabine and cisplatin plus trastuzumab in patients with HER2-overexpressing metastatic breast cancer: a phase II study
H J Stemmler, S Kahlert, O Brudler, et al.
British Journal of Cancer
|
February 4, 2015
Early detection of metastatic disease in asymptomatic breast cancer patients with whole-body imaging and defined tumour marker increase
D Di Gioia, P Stieber, G P Schmidt, et al.
Anticancer Research
|
November 1, 1989
Repeated blast crisis (BC) of changing morphology, immunologic phenotype and cytogenetics in chronic myeloid leukemia (CML)
U Jehn, J Mittermüller, L Greither, et al.
Anticancer Research
|
September 2, 1999
CA19-9: a pedictor of response in pancreatic cancer treated with gemcitabine and cisplatin
V Heinemann, M M Schermuly, P Stieber, et al.
Cancer Chemotherapy and Pharmacology
|
September 16, 2005
High efficacy of gemcitabine and cisplatin in patients with predominantly anthracycline- and taxane-pretreated metastatic breast cancer
V Heinemann, H J Stemmler, A Wohlrab, et al.
Anti-Cancer Drugs
|
October 14, 2005
Lasting remission following multimodal treatment in a patient with metastatic breast cancer
H J Stemmler, H Menzel, C Salat, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
July 16, 2014
Tumor markers CEA and CA 19-9 correlate with radiological imaging in metastatic colorectal cancer patients receiving first-line chemotherapy
M Michl, J Koch, R P Laubender, et al.
Annals of Hematology
|
April 22, 1999
Long-term outcome of hairy cell leukemia treated with 2-chlorodeoxyadenosine
U Jehn, R Bartl, H Dietzfelbinger, et al.
British Journal of Cancer
|
April 13, 2013
Cytokeratin 19-fragments (CYFRA 21-1) as a novel serum biomarker for response and survival in patients with advanced pancreatic cancer
S Boeck, C Wittwer, V Heinemann, et al.
Virchows Archiv : an International Journal of Pathology
|
December 10, 2020
Biomarker alterations associated with distinct patterns of metastatic spread in colorectal cancer
M Michl, F Taverna, J Kumbrink, et al.
Page
of 19